A certain type of diabetes drug may lower cancer risk in women with type 2 diabetes by up to one-third, while another type may increase the risk, according to a new study. Cleveland Clinic researchers analyzed data from more than 25,600 women and men with type 2 diabetes to compare how two groups of widely used diabetes drugs affected cancer risk. Read more here.
Study mentioned: Sun GEC, et al. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. Article first published online: 5 Dec 2013.
No comments:
Post a Comment